76 related articles for article (PubMed ID: 10466546)
1. Correlation between immunohistochemical and biochemical estrogen receptors in the prognosis of patients with breast cancer.
Chariyalertsak S; Thisuphakorn P; Ruangvejvorachai P
Asian Pac J Allergy Immunol; 1999 Jun; 17(2):107-12. PubMed ID: 10466546
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical detection using the new rabbit monoclonal antibody SP1 of estrogen receptor in breast cancer is superior to mouse monoclonal antibody 1D5 in predicting survival.
Cheang MC; Treaba DO; Speers CH; Olivotto IA; Bajdik CD; Chia SK; Goldstein LC; Gelmon KA; Huntsman D; Gilks CB; Nielsen TO; Gown AM
J Clin Oncol; 2006 Dec; 24(36):5637-44. PubMed ID: 17116944
[TBL] [Abstract][Full Text] [Related]
3. Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.
Regan MM; Viale G; Mastropasqua MG; Maiorano E; Golouh R; Carbone A; Brown B; Suurküla M; Langman G; Mazzucchelli L; Braye S; Grigolato P; Gelber RD; Castiglione-Gertsch M; Price KN; Coates AS; Goldhirsch A; Gusterson B;
J Natl Cancer Inst; 2006 Nov; 98(21):1571-81. PubMed ID: 17077359
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical detection of estrogen and progesterone receptors in primary breast cancer.
Chariyalertsak S; Chariyalertsak S; Ruangvejvorachi P
Asian Pac J Allergy Immunol; 1998 Dec; 16(4):161-6. PubMed ID: 10219897
[TBL] [Abstract][Full Text] [Related]
5. Comparison of new immunohistochemical assay for oestrogen receptor in paraffin wax embedded breast carcinoma tissue with quantitative enzyme immunoassay.
Saccani Jotti G; Johnston SR; Salter J; Detre S; Dowsett M
J Clin Pathol; 1994 Oct; 47(10):900-5. PubMed ID: 7962603
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous immunohistochemical and biochemical hormone receptor assessment in breast cancer provides complementary prognostic information.
Biesterfeld S; Schröder W; Steinhagen G; Koch R; Veuskens U; Schmitz FJ; Handt S; Böcking A
Anticancer Res; 1997; 17(6D):4723-9. PubMed ID: 9494596
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical analysis of estrogen receptors in breast carcinomas using monoclonal antibodies that recognize different domains of the receptor molecule.
Santeusanio G; Mauriello A; Ventura L; Liberati F; Colantoni A; Lasorella R; Spagnoli LG
Appl Immunohistochem Mol Morphol; 2000 Dec; 8(4):275-84. PubMed ID: 11127919
[TBL] [Abstract][Full Text] [Related]
8. Predictive value of estrogen receptors evaluated by quantitative immunohistochemical analysis in breast cancer.
Esteban JM; Ahn C; Battifora H; Felder B
Am J Clin Pathol; 1994 Oct; 102(4 Suppl 1):S9-12. PubMed ID: 7942615
[TBL] [Abstract][Full Text] [Related]
9. The prevalence of immunohistochemically determined oestrogen receptor positivity in primary breast cancer is dependent on the choice of antibody and method of heat-induced epitope retrieval - prognostic implications?
Grabau DA; Bendahl PO; Rydén L; Stål O; Fernö M;
Acta Oncol; 2013 Nov; 52(8):1657-66. PubMed ID: 23343224
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical detection of estrogen and progesterone receptors performed with an antigen-retrieval technique on methacarn-fixed paraffin-embedded breast cancer tissues.
Oyaizu T; Arita S; Hatano T; Tsubura A
J Surg Res; 1996 Jan; 60(1):69-73. PubMed ID: 8592434
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemically determined estrogen receptor phenotype remains stable in recurrent and metastatic breast cancer.
Gomez-Fernandez C; Daneshbod Y; Nassiri M; Milikowski C; Alvarez C; Nadji M
Am J Clin Pathol; 2008 Dec; 130(6):879-82. PubMed ID: 19019763
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical assay for oestrogen receptors in paraffin wax sections of breast carcinoma using a new monoclonal antibody.
Huang A; Pettigrew NM; Watson PH
J Pathol; 1996 Oct; 180(2):223-7. PubMed ID: 8976884
[TBL] [Abstract][Full Text] [Related]
13. [Expression of oestrogen receptor-beta in invasive breast tumours].
Péter I; Számel I; Péley G
Magy Onkol; 2004; 48(1):63-9. PubMed ID: 15105898
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical detection of hormone receptors in breast carcinomas (ER-ICA, PgR-ICA): prognostic usefulness and comparison with the biochemical radioactive-ligand-binding assay (DCC).
Beck T; Weikel W; Brumm C; Wilkens C; Pollow K; Knapstein PG
Gynecol Oncol; 1994 May; 53(2):220-7. PubMed ID: 8188083
[TBL] [Abstract][Full Text] [Related]
15. The utility of mitotic index, oestrogen receptor and Ki-67 measurements in the creation of novel prognostic indices for node-negative breast cancer.
Clahsen PC; van de Velde CJ; Duval C; Pallud C; Mandard AM; Delobelle-Deroide A; van den Broek L; van de Vijver MJ
Eur J Surg Oncol; 1999 Aug; 25(4):356-63. PubMed ID: 10419704
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of estrogen receptor status as assessed by ligand-binding assay in patients with early-stage breast cancer treated with breast conserving surgery and radiation therapy.
Takei H; Horiguchi J; Maemura M; Koibuchi Y; Oyama T; Yokoe T; Iino Y; Morishita Y
Oncol Rep; 2002; 9(2):375-8. PubMed ID: 11836611
[TBL] [Abstract][Full Text] [Related]
17. Determination of threshold values for determining the size of the fraction of steroid hormone receptor-positive tumor cells in paraffin-embedded breast carcinomas.
Leers MP; Hoop JG; van Beers M; van Rodijnen N; Pannebakker M; Nap M
Cytometry B Clin Cytom; 2005 Mar; 64(1):43-52. PubMed ID: 15668953
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors for survival after first recurrence in breast cancer: a retrospective analysis of 252 recurrent cases at a single institution.
Tsuji W; Teramukai S; Ueno M; Toi M; Inamoto T
Breast Cancer; 2014 Jan; 21(1):86-95. PubMed ID: 22477265
[TBL] [Abstract][Full Text] [Related]
19. [Clinical significance of steroid receptors in breast cancer].
Svastics E; Számel I; Ringwald G; Vincze B; Besznyák I; Tóth J
Orv Hetil; 1994 Mar; 135(10):513-7. PubMed ID: 8146006
[TBL] [Abstract][Full Text] [Related]
20. Neural Analyses Validate and Emphasize the Role of Progesterone Receptor in Breast Cancer Progression and Prognosis.
Caronongan A; Venturini B; Canuti D; Dlay S; Naguib RN; Sherbet GV
Anticancer Res; 2016 Apr; 36(4):1909-15. PubMed ID: 27069179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]